Cerebro (Cerebrolysin analogue) 212.5 mg/ml
research-grade
solution
in a 20 ml glass bottle. Cerebro is a Cerebrolysin-type peptide-based brain extract analogue studied in experimental models of neuronal survival, synaptic plasticity, cognitive function and recovery after functional impairment.
Research Use Only:
All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Purity
High-purity research grade
Content
212.5 mg Cerebro peptide mixture per 1 ml; 20 ml per bottle (total 4,250 mg per bottle)
Components / Contents
Porcine brain-derived peptide preparation (Cerebrolysin); mixture of low-molecular-weight peptides and free amino acids.
Packaging
20 ml glass bottle with sterile closure
Storage
2–8 °C, protect from light
CAS number
12656-61-0 (Cerebrolysin)
Research Overview
Cerebro is a Cerebrolysin-type peptide-based brain extract analogue modeled after neuropeptide fractions used in experimental neuroscience. In preclinical research, Cerebrolysin-style preparations are investigated for their potential to influence neuronal survival, synaptic plasticity, neurotrophic signaling and functional recovery in diverse central nervous system models.
Primary Research Areas
-
Neuroprotection and neuronal survival:
used in experimental models assessing resistance of neurons to metabolic stress, excitotoxicity and hypoxic or ischemic injury.
-
Synaptic plasticity and connectivity:
studied for effects on synapse density, neurite outgrowth and synaptic marker expression in in vitro and in vivo CNS systems.
-
Cognitive and behavioral models:
explored in laboratory paradigms probing learning, memory and functional task performance in animal models of cognitive impairment.
-
Neurotrophic and growth factor signaling:
used to investigate downstream pathways associated with BDNF, NGF and related neurotrophic systems, including intracellular kinase cascades.
-
Recovery after CNS damage:
included in research on functional recovery after CNS insults, focusing on structural remodeling, synaptic reorganization and motor/cognitive endpoint measures.
